The European regulator could give the green light from mid-December to market the anti-Covid vaccines developed by the American startup Moderna and by the Pfizer / BioNTech alliance, European Commission President Ursula von der announced on Thursday. Leyen.
Read also: Covid-19: how France is preparing for a very large vaccination campaign
The European Medicines Agency (EMA) is
"in daily discussions" with its American counterpart, the FDA, to "synchronize their evaluations"
, and the EMA could
"give conditional authorization to market Pfizer's vaccines / BioNTech and Moderna from the second half of December, if the procedures go smoothly
,
”
said the head of the European executive at the end of a summit of the Twenty-Seven by videoconference dedicated to the pandemic.